NCT04898738

Brief Summary

This project will build on an existing CDC funded cooperative agreement in the Dominican Republic with the Brigham and Women's Hospital (2018-2023) that includes (i) prospective COVID-19 and AFI surveillance at two health facilities and (ii) a nationally representative cross-sectional community-based serological survey of approximately 7,000 healthy adults and children targeting SARS-CoV-2 and other AFI pathogens to be conducted between April and June 2021. This linked study will establish a nested cohort of 2,000 participants enrolled in the national serological survey and prospectively monitor them for COVID-19 symptoms, conduct serial serological testing, implement molecular surveillance for SARS-CoV-2 and sequencing for variants of concern, implement and evaluate WASH mitigation measures, and monitor uptake and perceptions of COVID-19 vaccines.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,043

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 19, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 24, 2021

Completed
3 months until next milestone

Study Start

First participant enrolled

August 18, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 22, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 10, 2023

Completed
Last Updated

November 17, 2025

Status Verified

November 1, 2025

Enrollment Period

1.3 years

First QC Date

May 19, 2021

Last Update Submit

November 13, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Hand hygiene practices

    The average daily frequency of study participant hand hygiene events over the previous seven days will be assessed using standardized survey questionnaires at 0-, 3-, 6-, 9-, and 12-months.

    1 year

Secondary Outcomes (2)

  • Acceptability of hand hygiene technology

    1 year

  • SARS-Cov-2 seroconversion

    1 year

Study Arms (2)

Alcohol-based hand sanitizer

ACTIVE COMPARATOR

Half the study households with receive ABHS through the course of the study

Other: Alcohol based hand sanitizer

No Alcohol-based hand sanitizer

NO INTERVENTION

Half the study households with not receive ABHS through the course of the study

Interventions

Provision of ABHS to randomly selected households

Alcohol-based hand sanitizer

Eligibility Criteria

Age2 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Previously enrolled in a linked national community-based seroepidemiological study in the Dominican Republic
  • Agreed and consented to be recontacted to participate in additional research studies at the time of enrollment in #1
  • ≥2 years of age
  • Agree to participate

You may not qualify if:

  • Ward of the State

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Community study

Santo Domingo, Dominican Republic

Location

MeSH Terms

Conditions

COVID-19

Interventions

Ethanol

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

AlcoholsOrganic Chemicals

Study Officials

  • Eric J Nilles, MD

    Brigham and Women's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Model Details: This is a prospective cohort study that aims to prospectively monitor 2,000 community-based study participants with serial serological screening for SARS-CoV-2 and enhanced molecular surveillance for active infection. Nested within this cohort is a randomized trial that will allocate study participants into two arms: thoe that receive versus do not receive alcohol-based hand sanitizer (ABHS) through the course of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 19, 2021

First Posted

May 24, 2021

Study Start

August 18, 2021

Primary Completion

November 22, 2022

Study Completion

February 10, 2023

Last Updated

November 17, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will share

De-identified data for epidemiological analyses and modelling (including demographic data, clinical data, and survey questionnaire survey) will be shared with the following collaborators: Adam Kucharski (LSHTM), Colleen Lau (University of Queensland), Marietta Vasquez (Yale University), Matt Lozier (US CDC), Pardis Sabeti (Broad Institute), and staff at the Health Ministry Division of Epidemiology. Non-identifiable data shared with listed collaborators will be performed with secure file transfer.

Locations